Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

NXTC holding history

NextCure, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NXTC overviewAll 13F holders of NXTCFull Q2 2026 holdings

Shares (Q2 2026)
594
Value
$951
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NXTC by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026594$951<0.1%+256+75.7%AddedHolders
Q1 2026338$3.61K<0.1%00.0%UnchangedHolders
Q4 2025338$4.80K<0.1%−263−43.8%ReducedHolders
Q3 2025601$3.52K<0.1%−424−41.4%ReducedConverted for a 1-for-12 splitHolders
Q2 202512,299$5.66K<0.1%+3,762+44.1%AddedHolders
Q1 20258,537$4.10K<0.1%+4,335+103.2%AddedHolders
Q4 20244,202$3.24K<0.1%−1,264−23.1%ReducedHolders
Q3 20245,466$7.49K<0.1%−4,462−44.9%ReducedHolders
Q2 20249,928$15.8K<0.1%−885−8.2%ReducedHolders
Q1 202410,813$24.1K<0.1%+4,546+72.5%AddedHolders
Q4 20236,267$7.14K<0.1%−5,430−46.4%ReducedHolders
Q3 202311,697$15.1K<0.1%−3,967−25.3%ReducedHolders
Q2 202315,664$28.2K<0.1%+2,927+23.0%AddedHolders
Q1 202312,737$18.9K<0.1%+2,109+19.8%AddedHolders
Q4 202210,628$15.0K<0.1%+651+6.5%AddedHolders
Q3 20229,977$27.0K<0.1%+650+7.0%AddedHolders
Q2 20229,327$44.0K<0.1%+167+1.8%AddedHolders
Q1 20229,160$45.0K<0.1%+6,338+224.6%AddedHolders
Q4 20212,822$17.0K<0.1%+2,781+6,782.9%AddedHolders
Q3 202141$00.0%+23+127.8%AddedHolders
Q2 202118$00.0%−2,103−99.2%ReducedHolders
Q1 20212,121$21.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.